Stent Grafts Market - Global Forecast 2025-2032

The stent grafts market is rapidly evolving as healthcare providers and manufacturers respond to clinical complexity, technological advancements, and dynamic global conditions. Senior decision-makers require clear, actionable insight to maintain competitive advantage and drive operational excellence in this shifting landscape.

Market Snapshot: Stent Grafts Market Growth and Prospects

The stent grafts market grew from USD 5.72 billion in 2024 to USD 6.30 billion in 2025, with a 10.14% CAGR projected to reach USD 12.40 billion by 2032. Growth is propelled by the escalating global burden of cardiovascular conditions, rising demand for minimally invasive vascular procedures, and expanded adoption of image-guided interventions across various clinical settings. Leading companies are intensifying efforts in product development and streamlining operations to remain agile and aligned with shifting priorities in the vascular device sector.

Scope & Segmentation: Comprehensive Market Coverage Across Key Dimensions

This report delivers targeted insights to inform both strategic planning and operational execution by segmenting the stent grafts market along important vectors:

• Product Types: Covers aortic stent grafts for abdominal and thoracic aneurysm intervention, as well as peripheral stent grafts employed in lower limb and visceral artery treatment, reflecting the diversity of device applications in vascular medicine.
• Indications: Addresses devices for abdominal and thoracic aneurysm repair and for treatment of peripheral vascular disorders, helping refine tailored therapeutic protocols and support market expansion.
• End Users: Examines adoption patterns in hospitals and ambulatory surgical centers, providing insight into care setting preferences and evolving procedural landscapes.
• Delivery Mechanisms: Compares balloon expandable and self-expandable deployment systems, analyzing their clinical use cases and flexibility in addressing variable anatomical needs.
• Material Types: Investigates stent grafts constructed from expanded polytetrafluoroethylene (ePTFE) and polyester, assessing their durability, biocompatibility, and impact on device longevity.
• Configurations: Reviews bifurcated, branched, and straight stent graft designs, each addressing unique anatomical and procedural requirements, thereby supporting customization within practice.
• Regional Breakdown: Analyzes key trends in the Americas, EMEA, and Asia-Pacific, capturing nuances such as varying regulatory frameworks, local innovation catalysts, and specific drivers of stent graft adoption.
• Key Companies: Features major manufacturers including Medtronic plc, W. L. Gore & Associates, Terumo Corporation, Cook Medical, Boston Scientific, Endologix, Jotec GmbH, MicroPort Scientific, B. Braun Melsungen, and Bentley InnoMed, with mapping of corporate strategies and notable partnerships to their market dynamics.

Key Takeaways: Strategic Insights for Senior Decision-Makers

• Technological progress in stent graft design and materials improves safety and clinical effectiveness for increasingly complex patient groups, prompting continuous protocol refinement.
• Advancements in delivery systems and material engineering foster wider clinician confidence, supporting minimal invasiveness and procedural versatility across more diverse case profiles.
• Cross-sector collaboration involving manufacturers, research organizations, and clinical experts is reducing product development timelines and facilitating quicker market entry, especially in highly regulated jurisdictions.
• Growth of digital health integration and remote monitoring post-deployment is enhancing post-operative care and longitudinal patient tracking, thereby strengthening patient management and addressing complications proactively.
• Distinct regional factors, such as the rise of local manufacturing in Asia-Pacific, centralized procurement in EMEA, and the adoption of bundled care pathways in the Americas, are influencing commercial strategies and deployment approaches.

Tariff Impact: 2025 Tariff Revision Effects on Market Dynamics

New United States tariffs for 2025 have led to increased production costs for stent grafts through higher import duties. In response, companies are reassessing their supply chains, diversifying suppliers, building buffer inventories, and utilizing dual procurement models to secure uninterrupted device availability. These shifts are driving a move toward local manufacturing and greater supply chain resilience, minimizing both regulatory risk and trade-related cost fluctuations. Market leaders are consistently reviewing total landed costs and production strategies for optimized market positioning and compliance.

Methodology & Data Sources

This analysis draws on extensive secondary research from peer-reviewed journals, global regulatory frameworks, and patent databases. Expert interviews with vascular surgeons and industry leaders, combined with advanced scenario modeling, underpin the actionable insights and recommendations found in this report.

Why This Report Matters

• Enables senior leaders to identify high-growth opportunities and anticipate regulatory, operational, and technological risks within major stent graft segments across multiple regions.
• Supports informed investment and resource allocation decisions by clarifying emerging trends among both leading manufacturers and innovative market entrants.
• Provides actionable, data-driven recommendations to improve portfolio strategy, expedite market entry, and align distribution or pricing in competitive environments.

Conclusion

With clear market segmentation and perspective on disruptive forces, this report empowers decision-makers to refine strategy and capitalize on new opportunities in the evolving vascular intervention field.